Tango Therapeutics (TNGX) Advances Precision Cancer DrugsTango Therapeutics, Inc.BATS:TNGXtraderspro_chartsTango Therapeutics, Inc. (TNGX) develops targeted cancer therapies using synthetic lethality—an approach that attacks vulnerabilities unique to tumor cells while sparing healthy tissue. The company grows by advancing its clinical pipeline, leveraging precision genomics, and partnering with major pharma to accelerate development. Its strategy aims to deliver safer, more effective treatments for patients with genetically defined cancers. On the chart, TNGX posted a strong confirmation bar with rising volume as price moved above the .236 Fibonacci level and into the momentum zone. A trailing stop can be placed just under that .236 line using the Fibonacci snap tool, keeping risk controlled while momentum builds.